AzTrials
AzTrials

Migraine DiseaseNCT07028684

Effects of Foot Reflexology Massage in Migraine

A study testing Reflexology Massage in people with Migraine Disease, run by Karabuk University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Migraine is a primary headache type that usually manifests itself with unilateral, moderate to severe throbbing headaches, often accompanied by symptoms such as nausea, vomiting, and sensitivity to light and sound. Read more about this study

Who is it for?
Ages 18 to 45 years, women only
Conditions the study is for
Migraine Disease
What is being tested?
Reflexology Massage
Could I receive a placebo?
No, everyone receives an active treatment
How many people
22 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Jun 2025to 15 Mar 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Being between the ages of 18-45
  • Being diagnosed with migraine by a neurologist according to the International Headache Society (IHS) criteria
  • Volunteering to participate in the study
  • Being able to read and write
  • Not having entered menopause

Who cannot join

  • Any neurological or musculoskeletal disease other than migraine
  • History of cervical or cranial surgery
  • Irritation or ulceration on the skin area to be reflexologized
  • Receiving non-drug migraine treatment (acupuncture, dry needle, etc.)
  • Those who have received physiotherapy at least 6 months ago
  • Presence of diabetic foot
  • Open wounds on the foot
  • Pregnant individuals or individuals who become pregnant during the study

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Karabuk University

    Karabük

Other trials in Turkey (Türkiye)

About this study

Official title: Effects of Foot Reflexology Massage in Pain, Sleep and Quality of Life in Females With Migraine

Migraine is a primary headache type that usually manifests itself with unilateral, moderate to severe throbbing headaches, often accompanied by symptoms such as nausea, vomiting, and sensitivity to light and sound. The prevalence and impact of headaches are more pronounced, especially among women, and this condition is among the top five causes of disability in women. Reflexology, one of the complementary treatment methods, is an alternative medical practice that produces beneficial effects on the human body by applying pressure to specific points or areas called "reflex areas" on the feet, hands, and ears.The aim of this randomized controlled trial was to evaluate the effects of foot reflexology massage on pain, sleep, and quality of life in women with migraine. All patients included in this study will be evaluated with the following tests and scales three times: before, after, and 2 weeks after the end of the 5-week (10 sessions in total) treatment. After the initial evaluations of the study, migraine patients will be divided into 2 groups using a simple random sampling method in the computer randomization program. The first group will receive a foot reflexology massage. The second group will be the control group.

Read the detailed description

Migraine is a primary headache type that usually manifests itself with unilateral, moderate to severe throbbing headaches, often accompanied by symptoms such as nausea, vomiting, and sensitivity to light and sound. The prevalence and impact of headaches are more pronounced, especially among women, and this condition is among the top five causes of disability in women. Reflexology, one of the complementary treatment methods, is an alternative medical practice that produces beneficial effects on the human body by applying pressure to specific points or areas called "reflex areas" on the feet, hands, and ears. Reflexology can be used as a complementary or supportive method of treatment because it is a massage form that regulates complex body functions and has relaxing and loosening effects. In studies; It has been found that foot reflexology reduces patients' pain and improves their sleep quality. The aim of this randomized controlled trial was to evaluate the effects of foot reflexology massage on pain, sleep, and quality of life in women with migraine. All patients included in this study will be evaluated with the following tests and scales three times: before, after, and 2 weeks after the end of the 5-week (10 sessions in total) treatment. After the initial evaluations of the study, migraine patients will be divided into 2 groups using a simple random sampling method in the computer randomization program. The first group will receive a foot reflexology massage. The second group will be the control group.

Being tested
Reflexology Massage
Keywords
Migraine, Massage, Headache
Medical subject headings
Migraine Disorders, Headache

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Reflexology MassageOther

    Reflexology massage will be applied twice a week for 30 minutes per session, for a total of 10 sessions. The treatment will begin by relaxing the ankle with a few passive movements. Reflexology massage will be applied to the right foot first and then to the left foot.

    Target Areas to be Applied to the Right Foot: Brain, Pineal, Hypophysis, Hypothalamus and Thalamus, Temples, Eye area and Optic nerve, Ear area, Middle ear and Balance point, Neck.

    Other areas to be applied to the right foot: Thyroid and Parathyroid, Lung, Liver, Face area, Speech center and Thymus, Teeth, Diaphragm, Vertebra, Extremities.

    Areas to be applied to the left foot: Kidney, Diaphragm, Intestines, Neck, Vertebra, Extremities.

    The session is completed from the left foot by applying to the lymph inlet, lymph channel and diaphragm from both feet.

Study groups in NCT07028684
Study groupRoleWhat they receive
ControlNo interventionNo treatment other than medication will be given for migraine.
ExperimentalExperimentalReflexology massage will be applied twice a week for 30 minutes per session, for a total of 10 sessions.
Receives: Other: Reflexology Massage

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Visual Analog Scale

    Pain intensity will be assessed with a visual analog scale. The patient marks his/her own pain on a 10 (represents "worst pain imaginable") cm ruler with painlessness 0 (represents "no pain") at one end and the most severe pain possible at the other end.

    Measured: 5 weeks

Secondary outcomes (4)
  1. Headache Impact Test

    It will be used to measure the impact of headache on participants' quality of life. Items in this test assess areas such as vitality, pain and psychological distress, as well as sociability, role and cognitive functioning. Each item is answered on a 5-point Likert scale. The final score is determined by summing the scores on the six items, ranging from 36 to 78 points, with a higher score indicating a greater effect.

    Measured: Five weeks

  2. Pittsburgh Sleep Quality Index

    Sleep quality will be assessed with a scale consisting of 24 questions and 7 categories. Each item is evaluated with a score between 0 and 3, with 0 being no problems and 3 being serious problems. The total score is between 0-21. A high total score indicates poor sleep quality.

    Measured: Five weeks

  3. Migraine disability assessment

    It is a questionnaire that has proven to be reliable and valid in determining the degree of disability caused by migraine. MIDAS assesses the degree of disability from 1 to 4 based on the number of days (score). Grade I: Little or no disability (0-5 days), Grade II: Mild disability (6-10 days), Grade III: Moderate disability (11-20 days) and Grade IV (21+ days): Indicates severe disability.

    Measured: Five weeks

  4. 24-h Migraine Quality of Life Questionnaire

    The 24-hour quality of life scale will be used to evaluate the changes in the quality of life of the patients within 24 hours after the first dose of migraine medication. The scale has 3 sections and a total of 15 items covering quality of life areas under the headings of Migraine symptoms, Emotions, Worries, Work Functionality, Social Functionality, Energy-Vitality. The total score is minimum 15 and maximum 105. The higher the scores the individual receives from the scale, the higher the quality of life of the individual, and the lower the score, the lower the quality of life.

    Measured: Five weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Jun 2025
  2. Study start1 Jun 2025
  3. Primary completion15 Dec 2025
  4. Study completion15 Mar 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
The study includes two groups with massage and control group.
Masking
None (open label)
Enrolment
22 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07028684
Sponsor's protocol ID
KBU-FTR-2025-2178
Status last verified
Apr 2026
First submitted
11 Jun 2025
Last updated
15 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Reflexology Massage in people with Migraine Disease, run by Karabuk University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Visual Analog Scale (time frame: 5 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in